CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Lanreotide acetate

Last Updated: February 20, 2007
Result type: Reports
Project Number: SR0091-000
Product Line: Reimbursement Review

Generic Name: Lanreotide acetate

Brand Name: Somatuline Autogel

Manufacturer: Ipsen Limited

Therapeutic Area: Acromegaly

Indications: Acromegaly

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: July 19, 2007

Recommendation Type: List in a similar manner to other drugs in class